Wu TC et al. |
Genistein enhances the effect of trichostatin A on inhibition of A549 cell growth by increasing expression of TNF receptor-1. |
2012 |
Toxicol. Appl. Pharmacol. |
pmid:22626855
|
Luo SF et al. |
Activation of ROS/NF-kappaB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1beta-treated human tracheal smooth muscle cells. |
2009 |
Toxicol. Appl. Pharmacol. |
pmid:19281832
|
Henkens T et al. |
Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. |
2007 |
Toxicol. Appl. Pharmacol. |
pmid:17125810
|
Yan Y et al. |
Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. |
2003 |
Toxicol. Appl. Pharmacol. |
pmid:12902198
|
Ding SZ et al. |
Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. |
2013 |
Toxicol. Appl. Pharmacol. |
pmid:23518002
|
Van Beneden K et al. |
Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis. |
2013 |
Toxicol. Appl. Pharmacol. |
pmid:23707763
|
Weng YI et al. |
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells. |
2010 |
Toxicol. Appl. Pharmacol. |
pmid:20678512
|
Li X et al. |
Role of histone deacetylases(HDACs) in progression and reversal of liver fibrosis. |
2016 |
Toxicol. Appl. Pharmacol. |
pmid:27396813
|
Di Renzo F et al. |
Boric acid inhibits embryonic histone deacetylases: a suggested mechanism to explain boric acid-related teratogenicity. |
2007 |
Toxicol. Appl. Pharmacol. |
pmid:17320131
|
Busbee PB et al. |
Natural indoles, indole-3-carbinol and 3,3'-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression. |
2014 |
Toxicol. Appl. Pharmacol. |
pmid:24200994
|
Yan YE et al. |
Prenatal nicotinic exposure suppresses fetal adrenal steroidogenesis via steroidogenic factor 1 (SF-1) deacetylation. |
2014 |
Toxicol. Appl. Pharmacol. |
pmid:24709674
|
Yeh BW et al. |
Histone deacetylase inhibitor trichostatin A resensitizes gemcitabine resistant urothelial carcinoma cells via suppression of TG-interacting factor. |
2016 |
Toxicol. Appl. Pharmacol. |
pmid:26589485
|
Chen J et al. |
Prevention of cytotoxicity of nickel by quercetin: the role of reactive oxygen species and histone acetylation. |
2013 |
Toxicol Ind Health |
pmid:22294440
|
Bolleyn J et al. |
Effect of Trichostatin A on miRNA expression in cultures of primary rat hepatocytes. |
2011 |
Toxicol In Vitro |
pmid:21513791
|
Kang J et al. |
Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. |
2005 |
Toxicol In Vitro |
pmid:15649630
|
Sancak D and Ozden S |
Global histone modifications in Fumonisin B1 exposure in rat kidney epithelial cells. |
2015 |
Toxicol In Vitro |
pmid:26208285
|
de Boer J et al. |
Inhibition of histone acetylation as a tool in bone tissue engineering. |
2006 |
Tissue Eng. |
pmid:17518660
|
Jin H et al. |
HDAC inhibitor trichostatin A promotes proliferation and odontoblast differentiation of human dental pulp stem cells. |
2013 |
Tissue Eng Part A |
pmid:23013422
|
Dom G et al. |
5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro. |
2013 |
Thyroid |
pmid:23167291
|
Greenberg VL et al. |
Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. |
2001 |
Thyroid |
pmid:11349829
|